OPERA
EFFICACY
A real-world study of adult participants who switched to CABENUVA or a new oral ART regimen1
OPERA
SAFETY
- No safety or discontinuation data reported
Expert Perspectives: Conversations on CABENUVA
Real-world evidence from OPERA reinforces results from SOLAR
ART=antiretroviral therapy; ARV=antiretroviral; CI=confidence interval; CVF=confirmed virologic failure; EHR=electronic health record; INSTI=integrase strand-transfer inhibitor; IQR=interquartile range; NNRTI=non-nucleoside reverse transcriptase inhibitor; OR=odds ratio; PI=protease inhibitor.
Reference:
- Hsu RK, Sension M, Fusco JS, et al. Real-world effectiveness of cabotegravir + rilpivirine vs standard of care oral regimens in the US. Poster presented at: Retroviruses and Opportunistic Infections (CROI); March 3-6, 2024; Denver, CO.
PMUS-CBRWCNT250025